Skip to content
Precision for Medicine
New Whitepaper

Beyond Geography: A Former Regulator’s Perspective on Multiregional Oncology Trials

clinical-sample-kitting (1) sample-kitting

Custom Clinical Kitting Services

For Complex and Precision Medicine Trials

Integrating biomarker strategies with clinical operations to ensure sample integrity and regulatory compliance

In early-phase precision medicine trials, every sample holds significant value. Precision for Medicine specializes in bespoke kitting solutions that not only ensure accurate sample collection but also uphold the highest standards of regulatory compliance. Our blend of automation and human expertise allows us to adapt swiftly to the evolving needs of your trial, ensuring that your research progresses seamlessly.

Precision's newly updated facilities in Frederick, Maryland and Berlin, Germany provide global coverage, offering a reliable kitting partner with an approach designed to fit the specific needs of early-phase clinical trial kitting projects.

Key Differentiators

  • 01 icon-1

    Adaptive Kitting Strategies

    Tailored to meet the specific requirements of early-phase precision medicine trials.
  • 02 icon-1

    Regulatory Compliance

    Ensuring that all processes align with the latest industry standards and guidelines.
  • 03 icon-1

    Integrated Ecosystem

    Leveraging comprehensive expertise to support every phase of your trial.
  • 04 icon-1

    Enhanced Capabilities

    Our Frederick, MD and Berlin, Germany location enhancements improve our ability to manage intricate trial demands.

Explore How We Deliver Smarter Kitting

Discover how our tailored kitting solutions support complex clinical trials. Take a look at both a quick overview of our global capabilities and an in-depth case study on how Precision kitting enabled a cell therapy trial with complex requirements. 

Explore more Resources

Precision’s kitting, sample collection, and logistics services provide:

kit tubes

Kitting development and supply management

  • Trial and visit specific
  • Multiple sample types
  • Traceability of each component and expiry dates via 21CFR Part 11 compliant LIMS
  • Detailed kit status reporting
  • Sample collection training
Blood collection-1

Clinical site training

  • Collection-specific quality assurance plans
  • Development of training documentation
  • Competency and monitoring programs
global logistics-1

Logistics and transport management

  • Export/import permits
  • Late/evening shifts to receive deliveries and resolve shipment issues
  • Knowledge in planning best path for shipment
  • Ambient, refrigerated, or frozen shipment options
  • Experience with all major courierseg, QuickStat, World Courier, FedEx, Marken

Explore Precision’s other central lab services

  • Explore
    PBMC
    sample-processing

    PBMC & Sample Processing

    Sample processing with expertise in PBMC isolations from labs across 5 continents

    Explore
    sample-processing

    PBMC & Sample Processing

    Sample processing with expertise in PBMC isolations from labs across 5 continents

    Explore
  • Explore
    biostorage_card-thumbnail
    biospecimens

    Biostorage

    Sample storage under all conditions and temperatures, rapid sample accessioning, and online inventory access

    Explore
    biospecimens

    Biostorage

    Sample storage under all conditions and temperatures, rapid sample accessioning, and online inventory access

    Explore
  • Explore
    LabEportal

    Precision Lab e-Portal

    Real-time visibility into project, sample, kit, and shipment status provides 24/7 access to critical study data
    Explore

    Precision Lab e-Portal

    Real-time visibility into project, sample, kit, and shipment status provides 24/7 access to critical study data
    Explore

Explore the Precision blog

Read our blog to gain more insights and discover work that Precision has supported.

Read: Case Study: Swift Stabilization in Phase 1 Solid Tumor Rescue Case Study: Swift Stabilization in Phase 1 Solid Tumor Rescue

Clinical Trials - Oncology

Case Study: Swift Stabilization in Phase 1 Solid Tumor Rescue

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=205683637283, hs_child_table_id=0, hs_updated_at=1769114822287, hs_published_at=1769114824037, description=Karen Stokes is a dedicated, collaborative and solution-oriented drug development professional with over 25 years of experience in Data Management, Clinical Operations and Project Management on Phase I-IV studies in Academic and Contract Research Organization (CRO) environments.  She has expertise in CNS, Rare and Oncology indications and have successfully led cross functional teams to deliver quality on time.  , avatar=Image{width=208,height=246,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Karen%20Stokes.png',altText='Karen Stokes',fileId=205695655336}, lastname=Stokes, hs_initial_published_at=1769114824037, hs_created_by_user_id=26433386, hs_created_at=1769114779691, hs_is_edited=false, hs_deleted_at=0, name=Karen, job=Project Director, slug=karen-stokes, hs_updated_by_user_id=26433386}, second={hs_id=205683637278, hs_child_table_id=0, hs_updated_at=1769114711193, hs_published_at=1769114824037, description=Annie Raymond-Desgagné is a Principal Clinical Trial Manager specializing in oncology, known for her strong leadership, structured planning, and proactive mindset. She excels at building high‑performing teams, with a passion for mentoring and helping colleagues bring out the best in themselves. Skilled at implementing tools that improve forecasting and operational readiness, Annie consistently keeps teams two steps ahead in fast‑moving clinical environments. She has a particular affinity for first‑in‑human (FIH) studies, where the science unfolds in real time—an area that fuels her love of challenge and innovation. Collaborative, committed, and science‑driven, she brings clarity, foresight, and positive energy to every project she leads., avatar=Image{width=226,height=226,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/A%20person%20with%20short%20brown%20hair%20wearing%20glasses%20Description%20automatically%20generated.png',altText='A person with short brown hair wearing glasses Description automatically generated',fileId=205695412385}, lastname=Raymond-Desgagné, hs_initial_published_at=1769114715920, hs_created_by_user_id=26433386, hs_created_at=1769114644600, hs_is_edited=false, hs_deleted_at=0, name=Annie, job=Principal Clinical Trial Manager, slug=annie-raymond-desgagne, hs_updated_by_user_id=26433386}, third={}})
  • Karen S. avatar

    Karen S.

  • Annie R. avatar

    Annie R.

Discover
Read: The EU Biotech Act: What Sponsors Need to Know About Europe's Biotechnology Transformation The EU Biotech Act: What Sponsors Need to Know About Europe's Biotechnology Transformation

Clinical Trials - Regulatory

The EU Biotech Act: What Sponsors Need to Know About Europe's Biotechnology Transformation

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=195804116748, hs_child_table_id=0, hs_updated_at=1764696930757, hs_published_at=1769114824037, description=John is an experienced regulatory affairs consultant with more than 15 years of professional experience in drug development. He brings a proven track record in providing regulatory strategy, regulatory document development and review, and liaising with regulatory authorities., avatar=Image{width=276,height=290,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/John%20McIntyre.png',altText='John McIntyre',fileId=201584594055}, lastname=McIntyre, PhD, hs_initial_published_at=1757516163742, hs_created_by_user_id=26433386, hs_created_at=1757515873736, hs_is_edited=false, hs_deleted_at=0, name=John, job=Senior Director, Regulatory Strategy, slug=john-mcintyre, hs_updated_by_user_id=26433386}, second={}, third={}})
  • John McIntyre, PhD avatar

    John McIntyre, PhD

Discover
Read: Navigating Complexity: Rescuing a Biomarker-Driven Breast Cancer Trial Navigating Complexity: Rescuing a Biomarker-Driven Breast Cancer Trial

Clinical Trials - Oncology

Navigating Complexity: Rescuing a Biomarker-Driven Breast Cancer Trial

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=164725548848, hs_child_table_id=0, hs_updated_at=1754641451547, hs_published_at=1769114824037, description=Alexis Hobbins-White is an accomplished leader who plays a pivotal role in navigating the complex landscape of global oncology and rare disease-focused clinical trials. With a career spanning over 15 years in the clinical trials industry, Alexis brings a wealth of experience across multiple therapeutic areas, showcasing her proficiency in diverse aspects of operational strategy. She specializes in early phase adaptive studies, particularly in immuno-oncology and advanced therapeutics. She has an MSc in Neuroscience and an MA in Biotechnology Law and Ethics., avatar=Image{width=287,height=287,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/PfMxMarkentive/authors/Alexis-Hobbins.png',altText='Alexis-Hobbins',fileId=194096322982}, linkedin=https://www.linkedin.com/in/alexis-hobbins-white-400a1720/, lastname=Hobbins-White, hs_initial_published_at=1713362276020, hs_created_by_user_id=5166971, hs_created_at=1713361952861, hs_is_edited=false, hs_deleted_at=0, name=Alexis, job=Senior Director, Operational Strategy , slug=alexis-hobbins-white, hs_updated_by_user_id=26433386}, second={}, third={}})
  • Alexis Hobbins-White avatar

    Alexis Hobbins-White

Discover